| Term 
 
        | Levothyroxine sodium (Levothroid®, Synthroid®) |  | Definition 
 
        | Thyroid Hormone Replacement Use: DOC hypothyroidism, non-endemic goiter, hashimoto's, thyrotropin dependnt thyroid carcinoma Mechanism: Na salt of T4, may produce normal levels of T3 and T4
 Side effects: Hyperthyroidism effects;  Dx must be carefully titrated to the individual TSH levels should be measured 4 to 6 weeks after adjusting the dose of T4 Other drugs: Liothyronine sodium (Cytomel®) short half life and duration of action Liotrix (Euthroid®, Thyrolar®) - 4:1 ration T4:T3, no benefit; may cause cardiac palpitations, tachy, weight loss, insomnia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibitor of Thyroid hormone synthesis Use: Graves disease, for pts that can't tolerate methimazole, used in early pregnancy (methimazole = teratogenic_ Mechanism: Decreases synthesis and release of T4; blocks conversion of T4 to T3 Effects are gradual (use B-blockers) as circulating T3/T4 last a week or so  Side effects: itching, rash, sore throat, granulocytopenia, agranulocytosis Adverse: black box warning, severe liver injury/acute liver failure Other drug: Methimazole (Tapazole®) - DOC for graves now!; more potent         |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibitors of Thyroid Hormone synthesis Use: Graves disease? Prior to thyroid Sx, decreases vascularity to thyroid; prevent uptake of radioactive iodine in the event of accident where large quantitis of the radioctive compound might be released Mechanism: decreases T4 and T3; causes rapid decrease in release of thyroid hormone Effects wear off after 2-8 weeks |  | 
        |  | 
        
        | Term 
 
        | Radioactive iodine (131I) |  | Definition 
 
        | Inhibitor of Thyroid Hormone Synthesis Destroys thyroid gland in pts Use: Graves disease; hyperthyroid in elderly with heart disease; diagnostic procedures; thyroid ablation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B-adrenergic Blocking Agent Use: blocks symptoms of hyperthyroidism; used to prep for Sx while radioactive iodine takes effect Also decreases peripheral conversion of T4 to T3 by liver, reducing potency of thyroid hormone Contraindications: obstructive airway disease; asthma; caution in DM |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mechanism: inhibition of PTH secretion Use: osteoporosis: Ca alone can't prevent osteoporosis, but adequate Ca is needed for any other Tx to work |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mechanism: Increases GI Ca and phosphate absorption; Vit D must be adequate for optimal absorption of Ca Use: Vit D def, Rickets, Familial hypophosphatemia, hypoparathyroidism, osteomalacia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hormone Drug Use: Osteoporosis, prevent vertebral compression fractures Mechanism: inhibits bone resorption of Ca and phosphate by osteoclasts; antagonizes the actions of PTH PHK: intranasally or injected Adverse: Allergic reactions, rhinitis, sinusitis, nasuea vomiting |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hormone drug Use: Osteoporosis, the only anabolic osteoporosis therapy; hypoparathyroidism Mechanism: recombinant PTH; causes intermittent spikes of PTH Contraindications: osteosarcoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hormone Drug Use: Osteoporosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hormone Drug Use: Osteoporosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rank-Ligand inhibitors Use: Severe osteoporosis in postmenopausal women; increase bone mass and strength in both cortical and trabecular bone Mechanism: antibody to RANK-ligand, the factor made by osteoblasts that is necessary for the formation of mature osteoclasts Contraindications; hypocalcemia, pregnancy category X |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Biphosphate Use: First line Osteoporosis in men and post-menopausal women Mechanism: inhibits osteoclast activity and bone resorption; binds Ca salts, replacing phosphate and blocking hydroxyapatite PHK: absorption is very poor Adverse: Abdominal pain, upper GI irritation, esophageal ulceration, constipation, diarrhea, flatulence; renal tox if given too fast Other drugs: Etidronate (Didronel®)    Pamidronate (Aredia®) Ibandronate (Boniva®) Risedronate (Actonel®, Atelvia®)  Zoledronic acid (Reclast®) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Calcium receptor agonist Use: Osteoporosis Mechanism: calcimimetic and blocks PTH release |  | 
        |  |